Security key
00461U105
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)
CUSIP: 00461U105
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, $0.00001 par value
- Total 13F shares
- 65,900,596
- Total 13F value
- $1,037,946,141
- Share change
- -161,686
- Put/Call ratio
- 111%
- SEC-reported price per share
- $15.75
- Number of holders
- 126
- Value change
- -$2,542,115
- Number of buys
- 56
- Number of sells
- 44
- Shares outstanding
- 138,752,791
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
126
Top holders
10
ACRS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Aclaris Therapeutics, Inc. SEC filings
Aclaris Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00461U105
Recent filing periods:
Ownership snapshot
Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 3.5%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 3.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
3.5%
Venrock Adviser, LLC
3.3%
RA CAPITAL MANAGEMENT, L.P.
3.2%
BVF INC/IL
2.9%
Rock Springs Capital Management LP
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
3.5%
|
$75,714,000
4,810,298 shares
|
— | 30 Sep 2022 |
| Venrock Adviser, LLC |
13F
Company
|
3.3%
|
$71,837,000
4,563,962 shares
|
— | 30 Sep 2022 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
3.2%
|
$69,231,000
4,398,453 shares
|
— | 30 Sep 2022 |
| BVF INC/IL |
13F
Company
|
2.9%
|
$62,591,000
3,976,543 shares
|
— | 30 Sep 2022 |
| Rock Springs Capital Management LP |
13F
Company
|
2.9%
|
$62,350,000
3,961,249 shares
|
— | 30 Sep 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
2.5%
|
$54,364,000
3,453,853 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
126
Shares
65,900,596
Rows available
126
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2025 Across Filers
Q3 2025 holders
103
Q4 2022 holders
126
Holder diff
23
| Investor | Q3 2025 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend